Fundraising Fox
/Companies
Sign in

R3 Vascular

Mountain View, US · Founded 2019 · Delaware corporation · 1 known investors

Find your way into R3 Vascular

Sign up to find every way you can get introduced to R3 Vascular

  • Your email: who you already know at R3 Vascular, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the R3 Vascular team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

R3 Vascular develops bioresorbable vascular scaffolds made from a proprietary polymer using a proprietary manufacturing process. It operates in the medical device field for vascular treatment.

BiotechHealthtechMedical DevicesNew Materials

Founders & leadership

R3 Vascular was founded in 2019 by Kamal Ramzipoor.

KRKamal Ramzipoor
Kamal RamzipoorFounder and CTO
CM
Christopher M. OwensPresident and Chief Executive Officer
MR
Mahmood RazaviNamed on SEC filing
JM
JeanMarie MarkhamNamed on SEC filing

Board

FGFrederik Groenewegen
Frederik GroenewegenBoard directorGeneral Partner at 415 Capital
JS
John SpringerBoard director
MH
Michael HurleyBoard director
DN
David NeustaedterBoard director
NH
Nathan HarringtonBoard director
AA
Amir AbolfathiBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$75.2M disclosed across 2 rounds · 2019–2024

▶$72.5MraisedSep 2024 · 34 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kamal RamzipoorExecutive Officer
  • Frederik GroenewegenDirector
  • John SpringerDirector
  • Michael HurleyDirector
  • David NeustaedterDirector
  • Christopher M. OwensExecutive Officer, Director
  • Amir AbolfathiDirector
  • Nathan HarringtonDirector
Amount sold
$72.5M
Minimum investment
$331
First sale
Apr 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.7MraisedMay 2020 · 23 investors · Other Health Care
Rule 506(c)
Officers, directors & promoters on the filing
  • Kamal RamzipoorDirector
  • Mahmood RazaviDirector
  • JeanMarie MarkhamDirector
  • John SpringerExecutive Officer, Director
Offering amount
$3M
Amount sold
$2.7M
Minimum investment
$25K
Sales commissions
$15K
Proceeds to insiders
$450K
Placement agents
Beech Hill Securities, Inc
First sale
Aug 2019
Incorporated
Corporation, California, 2019
Federal exemptions
04, 06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

R3Enterprise blockchain/distributed ledger technology company led by David Rutter.

Companies working in the same space as R3 Vascular.

In the news

R3 Vascular Raises $87M in Series B Financingfinsmes.com · May 2024R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEOglobenewswire.com · May 2024

Frequently asked questions

What does R3 Vascular do?
R3 Vascular develops bioresorbable vascular scaffolds made from a proprietary polymer using a proprietary manufacturing process. It operates in the medical device field for vascular treatment.
Who founded R3 Vascular?
R3 Vascular was founded by Kamal Ramzipoor in 2019.
Who are R3 Vascular's investors?
R3 Vascular's investors include 415 Capital.
How much funding has R3 Vascular raised?
R3 Vascular has disclosed $75.2M raised across 2 rounds.
Where is R3 Vascular headquartered?
R3 Vascular is headquartered in Mountain View, US.